株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の出生前・新生児遺伝子検査市場

Global Prenatal and Newborn Genetic Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 322258
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
世界の出生前・新生児遺伝子検査市場 Global Prenatal and Newborn Genetic Testing Market 2015-2019
出版日: 2014年12月31日 ページ情報: 英文 70 Pages
概要

出生前・新生児遺伝子検査には、出生前後の遺伝子検査が含まれます。出生前検査は、出生前に胎児の変化を検出することが可能です。世界の出生前・新生児遺伝子検査市場は、2014年〜2019年のCAGRで、31.91%の増加が予測されています。

当レポートでは、世界の出生前・新生児遺伝子検査市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 市場区分:技術別

第8章 出生前スクリーニング検査

第9章 原因と危険因子

第10章 出生前の遺伝性疾患

第11章 地域区分

第12章 購入基準

第13章 市場成長促進要因

第14章 促進要因とその影響

第15章 市場の課題

第16章 促進要因と課題の影響

第17章 市場動向

第18章 動向とその影響

第19章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第20章 主要ベンダーの分析

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Sequenom
  • Illumina

第21章 関連レポート

図表

目次
Product Code: IRTNTR4941

About Prenatal and Newborn Genetic Testing

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.

TechNavio's analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Prenatal and Newborn Genetic Testing market for the period 2015-2019. The Global Prenatal and Newborn Genetic Testing market can be divided into two segments: Diagnostic Techniques and Screening Methods. To calculate the market size, the report considers revenue generated from these segments.

TechNavio's report, the Global Prenatal and Newborn Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Prenatal and Newborn Genetic Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Illumina
  • Sequenom

Market Driver

  • Growing Incidences of Fetal Health-related Abnormalities
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in Fertility Rates
  • For a full, detailed list, view our report

Market Trend

  • Increase in Number of New Product Launches
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Prenatal Screening Tests

09. Causes and Risk Factors

10. Genetic Disorders before Birth

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2014
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Agilent Technologies
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation by Revenue 2013
    • 20.1.4. Product Portfolio by Revenue 2013
    • 20.1.5. Business Segmentation by Revenue 2012 and 2013
    • 20.1.6. Geographical Segmentation by Revenue 2013
    • 20.1.7. Business Strategy
    • 20.1.8. Recent Developments
    • 20.1.9. SWOT Analysis
  • 20.2. Bio-Rad Laboratories
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Business Segmentation by Revenue 2013
    • 20.2.4. Product Portfolio by Revenue 2013
    • 20.2.5. Business Segmentation by Revenue 2012 and 2013
    • 20.2.6. Geographical Segmentation by Revenue 2013
    • 20.2.7. Business Strategy
    • 20.2.8. Recent Developments
    • 20.2.9. SWOT Analysis
  • 20.3. Sequenom
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation by Revenue 2013
    • 20.3.4. Product Portfolio by Revenue 2013
    • 20.3.5. Business Segmentation by Revenue 2012 and 2013
    • 20.3.6. Geographical Segmentation by Revenue 2013
    • 20.3.7. Business Strategy
    • 20.3.8. Recent Developments
    • 20.3.9. SWOT Analysis
  • 20.4. Illumina
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation by Revenue 2013
    • 20.4.4. Product Portfolio by Revenue 2013
    • 20.4.5. Business Segmentation by Revenue 2012 and 2013
    • 20.4.6. Geographical Segmentation by Revenue 2013
    • 20.4.7. Business Strategy
    • 20.4.8. Recent Developments
    • 20.4.9. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Prenatal and New-born Genetic Testing Market 2014-2019 (US$ billion)
  • Exhibit 3: Global Prenatal and New-born Genetic Testing market Segmentation by Technology
  • Exhibit 5: Global Prenatal and New-born Genetic Testing Market Segmentation by Technology
  • Exhibit 6: Global Prenatal and New-born Genetic Testing Market Segmentation by Type of Test
  • Exhibit 7: Global Diagnostic Techniques Market Segmentation by Type of Test
  • Exhibit 8: Global Screening Methods Market Segmentation by Type of Test
  • Exhibit 9: Causes and Risk Factors of Prenatal and New-born Genetic Testing
  • Exhibit 10: Various Genetic Disorders before Birth
  • Exhibit 11: Global Prenatal and New-born Genetic Testing Market by Geographical Segmentation 2014
  • Exhibit 12: Global Incidence of Chromosomal Abnormalities in New-borns
  • Exhibit 13: Declining Fertility Rates
  • Exhibit 14: Spontaneous Abortions and Fertility Rates as a Function of Maternal Age
  • Exhibit 15: Risks of Down Syndrome and Chromosomal Abnormalities at Live Birth, According to Maternal Age
  • Exhibit 16: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 17: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 18: Agilent Technologies: Sales by Geography 2013
  • Exhibit 19: Bio-Rad Laboratories: Business Segmentation by Revenue 2013
  • Exhibit 20: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 21: Bio-Rad Laboratories: Sales by Geography 2013
  • Exhibit 22: Sequenom: Business Segmentation by Revenue 2013
  • Exhibit 23: Sequenom: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 24: Sequenom: Sales by Geography 2013
  • Exhibit 25: Illumina: Business Segmentation by Revenue 2013
  • Exhibit 26: Illumina: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 27: Illumina: Sales by Geography 2013
Back to Top